Vanguard Group Portfolio holdings
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.18B |
| 2 |
Medtronic
MDT
|
+$2.06B |
| 3 |
Microsoft
MSFT
|
+$1.61B |
| 4 |
Procter & Gamble
PG
|
+$1.47B |
| 5 |
UBS Group
UBS
|
+$1.01B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.42B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$2.34B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$930M |
| 4 |
Apple
AAPL
|
+$637M |
| 5 |
SWY
SAFEWAY INC
SWY
|
+$620M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.67% |
| 2 | Technology | 13.6% |
| 3 | Financials | 13.57% |
| 4 | Industrials | 10.71% |
| 5 | Consumer Discretionary | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ANTH
3026
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $4.71M | ﹤0.01% |
131,810
+62,998
| +92% | +$1.86M |
|
|
FLXN
3027
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $4.69M | ﹤0.01% |
208,370
+82,313
| +65% | +$1.91M |
|
|
MPX
3028
DELISTED
Marine Products Corp
MPX
| $4.69M | ﹤0.01% |
547,557
+27,516
| +5% | +$220K |
|
3029
Goldgroup Mining Inc.
GORO
$191M
| $4.69M | ﹤0.01% |
1,469,782
+36,736
| +3% | +$123K |
|
|
CACB
3030
DELISTED
Cascade Bancorp
CACB
| $4.67M | ﹤0.01% |
973,186
+21,960
| +2% | +$105K |
|
3031
Artesian Resources
ARTNA
$358M
| $4.66M | ﹤0.01% |
217,782
+477
| +0.2% | +$10.4K |
|
3032
United States Lime & Minerals
USLM
$3.44B
| $4.65M | ﹤0.01% |
360,585
+21,640
| +6% | +$297K |
|
|
GEN
3033
DELISTED
Genesis Healthcare, Inc.
GEN
| $4.65M | ﹤0.01% |
+652,788
| New | +$4.92M |
|
|
GLBR
3034
DELISTED
Global Brokerage, Inc. Class A Common Stock
GLBR
| $4.62M | ﹤0.01% |
217,136
-38,749
| -15% | -$1.76M |
|
3035
TechTarget
TTGT
$278M
| $4.61M | ﹤0.01% |
399,473
+45,578
| +13% | +$521K |
|
|
EMKR
3036
DELISTED
Emcore Corp
EMKR
| $4.61M | ﹤0.01% |
84,664
+4,324
| +5% | +$231K |
|
3037
Regional Management Corp
RM
$303M
| $4.6M | ﹤0.01% |
311,953
+31,514
| +11% | +$485K |
|
|
AXIA.PR
3038
DELISTED
AXIA Energia American Depositary Shares Preferred Class B1
AXIA.PR
| $4.6M | ﹤0.01% |
2,765,442
+29,971
| +1% | +$56.8K |
|
3039
Fortress Biotech
FBIO
$88.7M
| $4.58M | ﹤0.01% |
79,261
+1,554
| +2% | +$64.8K |
|
|
MAG
3040
DELISTED
MAGNETEK INC COM STK NEW
MAG
| $4.56M | ﹤0.01% |
118,480
+4,677
| +4% | +$189K |
|
3041
Amtech Systems
ASYS
$272M
| $4.56M | ﹤0.01% |
408,159
+81,395
| +25% | +$818K |
|
3042
First Bancorp
FNLC
$399M
| $4.56M | ﹤0.01% |
261,109
+6,031
| +2% | +$102K |
|
|
XBKS
3043
DELISTED
Xenith Bankshares, Inc. Common Stock
XBKS
| $4.54M | ﹤0.01% |
240,465
+387
| +0.2% | +$6.5K |
|
3044
Northrim BanCorp
NRIM
$587M
| $4.54M | ﹤0.01% |
739,688
+8,396
| +1% | +$48.2K |
|
3045
MGP Ingredients
MGPI
$375M
| $4.53M | ﹤0.01% |
336,585
+1,200
| +0.4% | +$18.2K |
|
3046
Superior Group of Companies
SGC
$225M
| $4.53M | ﹤0.01% |
238,580
+8,500
| +4% | +$156K |
|
|
FWM
3047
DELISTED
FAIRWAY GROUP HLDGS CORP CL A COM STK (DE)
FWM
| $4.52M | ﹤0.01% |
668,119
+43,123
| +7% | +$216K |
|
|
JMI
3048
DELISTED
JAVELIN MTG INVESTMENT CORP COM
JMI
| $4.51M | ﹤0.01% |
596,373
-169,223
| -22% | -$1.53M |
|
3049
Clearfield
CLFD
$374M
| $4.5M | ﹤0.01% |
303,981
+13,947
| +5% | +$186K |
|
3050
Orrstown Financial Services
ORRF
$838M
| $4.49M | ﹤0.01% |
262,687
+1,200
| +0.5% | +$20.3K |
|
Similar funds
Vanguard Group's Q1 2015 Portfolio in Review
As of Q1 2015, Vanguard Group held 4,228 positions worth $1.47T, up 6.2% from $1.39T the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Vanguard Group deployed $66B of net new capital in Q1 2015, opening 181 new positions and adding to 3,456 existing holdings. Its largest new stake was UBS Group: 57,940,325 shares worth $1.09B.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $637M trimmed.
- Vanguard Group's largest Q1 2015 buy was UBS Group: 57,940,325 shares worth $1.09B.
- Vanguard Group added most to Allergan plc in Q1 2015, an estimated $2.18B increase.
- Vanguard Group's biggest Q1 2015 reduction was Apple, cutting an estimated $637M.
- Vanguard Group fully exited Allergan Inc in Q1 2015, selling an estimated $3.42B.
- Vanguard Group's ten largest holdings make up 12% of its $1.47T portfolio in Q1 2015.
- Vanguard Group opened 181 new positions and closed 75 in Q1 2015.
- Vanguard Group's portfolio value rose 6.2% quarter-over-quarter to $1.47T.
Based on Vanguard Group's 13F filing for Q1 2015, filed 14 May 2015.